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Abstract
Mosquito-borne viral diseases are infections transmitted by the bite of infected 
mosquitoes. The burden of these diseases is highest in tropical and subtropical 
areas and they disproportionately affect the poorest populations. Since 2014, major 
outbreaks of dengue, chikungunya, yellow fever and Zika have afflicted popula-
tions and overwhelmed health systems in many countries. Distribution of mos-
quito-borne diseases is determined by complex demographic, environmental and 
social factors, causing diseases to emerge in countries where they were previously 
unknown. Coupling genomic diagnostics and epidemiology to innovative digital 
disease detection platforms raises the possibility of an open, global, digital pathogen 
surveillance system. Considering pathogen surveillance in mind, real-time sequenc-
ing, bioinformatics tools and the combination of genomic and epidemiological data 
from viral infections can give essential information for understanding the past and 
the future of an epidemic, making possible to establish an effective surveillance 
framework on tracking the spread of infections to other geographic regions.
Keywords: mosquito-borne viral diseases, arboviral infections, genomics 
epidemiology, next-generation sequencing, genomic surveillance, viral pathogens
1. Introduction
Mosquito-borne viral diseases have lately integrated worldwide headlines since 
the emergence of arbovirus outbreaks in big urban areas. According to the World 
Health Organization, more than 17% of all infectious diseases registered worldwide 
are represented by vector-borne diseases, and they account for more than 700,000 
deaths annually [1]. Due to this scenario of increasing cases number and expansion 
to new areas, the spread of infectious diseases was listed second in the top 10 risks 
in term of impact according to the Global Risks 2015 report [2].
Mosquitos of the genus Aedes have been responsible for the emergence and 
re-emergence of many arboviral diseases worldwide [3]. The species Aedes aegypti 
is the main vector species responsible for the major arbovirus epidemics recorded 
in recent years [4]. The species A. aegypti and A. albopictus are possibly suitable 
to survive and establish in 215 countries/territories, and their expanding range 
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is underlined by the increasing number of countries reporting transmission of 
mosquito-borne viruses. Transmissions of arboviruses, such as Zika, dengue, 
chikungunya, yellow fever, and Rift Valley fever, have been reported in 85, 111, 
106, 43, and 39 countries, respectively [5]. Projections indicated that 3.83 billion 
people are living in areas prone to transmission of dengue and it is predicted that 
by 2050 large increases in dengue suitability will be seen in southern Africa and 
in the Sahel in West Africa [14]. Bhatt et al. projected the global burden of dengue 
around the world whose estimate indicated that 96 million dengue infections 
occur per year worldwide and this number represents infections that manifest at 
any level of the disease severity [6]. the Americas, comprising North and South 
America, registered more than 2 million dengue cases in 2016, and more than 1.4 
million cases in 2019 [7]. For chikungunya fever, the Americas registered more 
than 94,000 cases in 2018, and in that same region, Zika fever accounted for more 
than 650,000 cases in 2016 [8, 9]. High number of cases of arboviral diseases was 
also registered in other regions in recent years, such as in the western pacific region 
where more than 375,000 suspected dengue cases were reported in 2016 [10]. In 
Africa, the government of Congo reported 6149 suspected cases of chikungunya 
until April 2019, and more than 13,000 chikungunya cases were reported in 
Sudan until October 2018 [11, 12]. The increasing in frequency and distribution 
of arboviral diseases in recent years represents a worrying burden not only for 
the public health system, but also for the economic sector [3]. Some estimates 
of the economic costs of arboviral infections have been made and for the case 
of dengue infections, it has been estimated that the median cost of all reported 
dengue hospital admissions registered in a municipality from Brazil was US$ 259.9 
per hospitalization [13, 17]. Also, in Maldives, in the Indian Ocean, dengue fever 
represented a total cost of $3 million in 2015 [14]. Another estimate indicated that 
West Nile fever hospitalized cases in US represented a total cumulative cost of $778 
million between 1999 and 2012 [15].
Dengue and chikungunya are two arboviral diseases present in the list of 
neglected tropical diseases from the World Health Organization. Neglected tropi-
cal diseases are a group of diseases that have received insufficient public attention, 
strive in tropical and subtropical areas, and strongly affect populations living in 
poverty [12]. It is argued that arboviruses can be considered a group of neglected 
tropical diseases, since they can have a long-lasting impact in the health and 
economic life of affected populations [16]. Some studies have argued that socioeco-
nomic factors and land-use changes associated with the effects of climate change 
and global travel, and trade modulate the dynamics of expansion of emerging e 
re-emerging mosquito-borne diseases [17–20]. Movement of people between neigh-
boring countries has been considered a good predictor for chikungunya spread in 
the Caribbean and Indian Ocean [14]. The expansion of the geographic distribution 
of arbovirus has significant negative impact on public health in many regions of the 
world. As measures to reduce such impacts, it has been argued about the relevance 
to public health of the implementation of a surveillance system that monitors virus 
diffusion and the appearance of new genetic variants [21]. In this sense, the use of 
genomic sequencing data and bioinformatics has been employed in the study of 
virus evolution, aiming to elucidate phylogenetic relationships and patterns of virus 
spread during an epidemic [22].
2. Genomic surveillance
Infectious diseases continue to be one of the leading causes of death worldwide 
[23] and pathogens such as viruses can evolve and spread rapidly, leading to the 
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emergence of newly-mutated human pathogens, more virulent strains, as well as 
antibiotic and drug resistant organisms [24, 25]. In this context, genomic surveil-
lance aims are to: (i) to perform global surveillance of pathogens using whole 
genome sequencing and (ii) to understand drug resistance, emergence and spread 
of viral pathogens. Several approaches have been developed and are widely used for 
the quick detection and identification of viral pathogens (i.e., diagnostics). Some 
of them are based on different serological and molecular strategies including, for 
example, assays based on real-time polymerase chain reaction [26]. Even though 
these kinds of approaches present high sensitivity and specificity for their purpose, 
they are more suitable for diagnostics only and cannot provide detailed genomic 
information [27].
Bearing these limitations in mind, the main point of developing new genomic 
surveillance tools is to answer the following inquiry: what sort of questions is 
important for genomic surveillance that cannot be addressed by conventional 
RT-qPCR or serology? (i) RT-qPCR assays do not allow genotype classification, nei-
ther does it help identify particular and/or characteristic transmission routes; (ii) 
RT-qPCR assays also do not allow to determine how fast a viral pathogen is being 
transmitted and in what direction it is spreading; (iii) serological and molecular 
assays also cannot help identify epidemiologically linked individuals, neither pre-
dict future outbreaks; and (iv) finally, serological and some molecular approaches 
cannot help to identify novel pathogenic agents and are, therefore, unsuitable for 
pathogen discovery [27].
Next generation sequencing (NGS) technologies produce significantly more raw 
data than other molecular diagnostic assays, including Sanger sequencing, and are 
also capable of informing not just pathogen diagnostics but also epidemiology [28]. 
This is why whole genome sequencing of viral genomes by using new technologies 
plays an important role in the fight against emerging and re-emerging epidemics 
[29, 30]. The availability of high-throughput sequencing has also provided immense 
insights into the ecology of health care-associated pathogens [31]. Therefore, real-
time sequencing of entire pathogen genomes has become a standard and indispens-
able research tool for the critical role of genomic surveillance in the prevention 
and control of emerging infectious diseases [32], which justifies why NGS can be 
considered a powerful strategy that also allows the discovery of novel potential viral 
pathogens [33, 34].
Considering pathogen surveillance in mind, bioinformatics tools and the combi-
nation of genomic and epidemiological data from viral infections can give essential 
information for understanding the past and the future of an epidemic, because 
genomic data generated by real-time sequencing can provide important information 
on how and when viruses were introduced in a particular site, their pattern and deter-
minants of dissemination in neighboring locations and the extent of genetic diversity, 
i.e., its dynamics, making it possible to establish an effective surveillance framework 
on tracking the spread of infections to other geographic regions [21, 22, 34]. In this 
context, recently established international networks for real-time, portable genomic 
sequencing, genomic surveillance and data analysis made it possible to monitor the 
evolution of viral genomes, to understand the origins of outbreaks and epidemics, 
to predict future outbreaks and to assist in the maintenance of updated diagnostic 
methods [33–35]. Additionally, genomic surveillance framework allows to determine, 
through genome sequencing, the real-time molecular epidemiology of viruses circu-
lating and co-circulating in different regions in a specific area, and also to detect and 
characterize the early emergence of new pathogens in large urban centers, generating 
data that can inform outbreak control responses [27, 34]. Generated data regarding 
the molecular, epidemiological, phylogenetic and geographical aspects of circulating 
viral pathogens in a specific setting contribute to a better understanding of those 
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viral infections in a national and international context, assuming an important role 
in solving issues relevance to Public Health [35]. As a result, studies involving more 
in-depth molecular and dispersion analysis of circulating pathogens may help the 
World Health Organization appropriately adopt measures to control epidemics 
and to monitor the dynamics and spreading of new viral strains. However, even 
though NGS has advantages over diagnostics routine, all of the different strategies 
and technologies, developed by Illumina, Thermo Scientific, Oxford Nanopore and 
others, are not yet considered a panacea. Remaining challenges include dealing with 
high data throughput, which requires sophisticated computational processing as 
well as the annotation of large amounts of sequencing data, high DNA or RNA input 
sample requirements (in some cases hundreds of nanograms), which often raises the 
need for previous PCR-based amplification approaches. On top of all this, there are 
relatively few researchers in the area with sufficient bioinformatics expertise and who 
are able to engage in near-patient or disease surveillance activities [35].
3. Bioinformatics tools and phylogenetic tools
The advent of next generation sequence (NGS) and advancements in bioin-
formatics present an opportunity to tap into new insights that are crucial to the 
establishment of an open, global digital surveillance system. NGS technologies 
have enabled the production and deposit of vast amounts of whole genomes into 
public repositories [36–38] ushering the field of genomics into era of big data. This 
has in turn increased the scale of genomic studies from the analysis of single or few 
genomes to an ever-increasing large number of genomes [39, 40].
Toward the development of global surveillance system, bioinformatics provides 
the tools to answer pertinent questions including the identification of organisms 
responsible for an outbreak, the source of an outbreak and evolutionary informa-
tion of pathogens crucial for understanding the unique phenotypes such as drug 
resistance, virulence and disease outcome.
Several bioinformatics tools and pipelines have been developed to facilitate the 
processing, analysis and visualization of these data in order to derive useful infor-
mation from it [41]. The major fields of interest addressed by these tools include 
comparative genomics which involves comparing the genetic content of one organ-
ism against that of another; prediction of the function of genes and sequences of 
the coding regions; identification of evolutionary events and inference of phyloge-
netic relationships. These fields of study play a critical role in elucidating pathogen 
evolution, niche adaptation, population structure and host-pathogen interaction. 
Furthermore, these findings inform vaccine and drug design, as well as the identifi-
cation of virulence genes.
4. Bioinformatics pipelines and workflows
Bioinformatics pipelines and workflows comprise of a series of third-party 
executable command line software assembled to perform a specific task or analysis. 
A complete pipeline will, therefore, be able to support the end of analysis of a given 
field of study such as phylogenetics or variant detection. Pipelines can thus be 
broken down into two major components i.e. the data processing component and 
the analytical component that performs the core analysis of the pipeline. Below, we 
review some of the prominent bioinformatics pipelines and workflows that sup-
port the processing and analysis of NGS data to provide insights on relevant global 
surveillance of arboviral outbreaks.
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5. Virus discovery and identification tools
Viral discovery and identification from isolates and metagenomic samples pres-
ent major challenges to bioinformatics in general. This is because viral genomes are 
prone to very high variability and deviation from reference genomes [42], continu-
ous emergence of new viruses with no available references, high intrapopulation 
diversity, and the relative rareness of viral DNA fragments in metagenomic samples 
[43]. These challenges have largely been addressed through the following pipelines.
5.1 Genome detective
Genome detective (http://www.genomedetective.com/app/) is an easy to use 
web-based software application that assembles the genomes of viruses quickly and 
accurately, designed to generate and analyze whole or partial viral genomes directly 
from NGS reads within minutes [44]. The application gains accuracy by using a 
novel alignment method that uses a combination of both amino acids and nucleo-
tide scores to construct genomes by reference-based linking of de novo contigs. 
Speed and accuracy are also gained by using DIAMOND [45] with a UniProt90 
reference dataset to sort viral taxonomy units. The use of DIAMOND and UniRef90 
allowed genome detective to identify viral short reads at least 1000 times faster than 
when Blastn and the viral nucleotide database of NCBI were used. The software 
was optimized using synthetic datasets to represent the great diversity of virus 
genomes. The application was then validated with next-generation sequencing data 
of hundreds of viruses.
5.2 VirusTAP: viral genome-targeted assembly pipeline
One of the major difficulties in this process is the correct de novo assembly of 
viral genomes from crude metagenomic deep sequencing reads, including large 
amounts of bacteria and human related sequencing reads. Such read contaminations 
often force the server to overload during de novo assembly and might cause misas-
sembly of the resultant contigs. Pre-filtering by host-mapping subtraction could 
lead to efficient de novo assembly, allowing the rapid and accurate procurement of 
a complete viral genome sequence. In addition to the accuracy of de novo assembly, 
the exclusion of human-related sequences can circumvent conflicting ethical issues 
by avoiding analyzing the personal genetic information of patients [46, 47].
VirusTAP is web-based, integrated NGS analysis tool designed to facilitate rapid 
and accurate viral genome assembly from raw reads by just clicking on several selec-
tions. Like genome detective, it ensures that non-viral reads are eliminated prior to 
de novo assembly in order to ensure performance is not compromised.
5.3 Virus identification pipeline (VIP)
VIP (https://github.com/keylabivdc/VIP) is a web-based virus discovery and 
identification tool [46]. With a single click, it will filter out background-related 
reads, classify reads on basis of nucleotide and remote amino acid homology, and 
perform phylogenetic analysis to provide evolutionary insights.
5.4 TAR-VIR: a pipeline for TARgeted VIRal strain reconstruction from 
metagenomic data
TAR-VIR is a non-reference based NGS analysis tool for the reconstruction of 
viral strains from metagenomic samples [46, 47]. It was developed to classify RNA 
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viral reads from viral metagenomic data and also to produce the assembled viral 
strains (i.e. haplotypes) from classified reads. It mainly has two components: (1) 
viral read classification using partial or remotely related reference genomes and (2) 
de novo assembly of viral haplotypes from recruited reads with PEHaplo [47, 48], 
which is a haplotype reconstruction tool. As TAR-VIR has a modular structure, the 
users have options to use other assembly tools after read classification in step (1).
6. Genotyping tools
While variant discovery and identification tools play a critical role in determining 
the pathogen responsible for the infection, they are unable to determine the subtype 
or quasispecies that is responsible for the outbreak. Arboviruses exist as a mixed 
population of genomic variants due to rapid replication and the error prone nature 
of viral RNA-dependent RNA polymerase (RdRp) [47]. Monitoring virus genotype 
diversity is therefore crucial to understand the emergence and spread of outbreaks. 
Genotyping tools provide an efficient workflow to enable researchers and public 
health practitioners to determine the strain that is responsible for the outbreak.
Most free-access bioinformatics programs used to classify the genetic profile of 
subtypes, genotypes, subgroups or groups of viruses are based on the use of similar-
ity search tools to determine the genotype of a new sequence. These genotyping 
tools use a set of reference sequence genomes, carefully selected for the purpose of 
representing each individual genotype. The use of a number of reference sequences 
representing the genotype of a given group increases the consistency and repro-
ducibility of the data, thus ensuring a higher speed in the search for the data and 
offering greater and more complete information while ensuring that the results are 
not limited to an inadequate set of reference sequences that do not represent the 
information needed to identify the virus.
The similarity-based methods are useful for identifying recombination patterns 
in viral sequences, but they need further confirmation of their own phylogenetic 
methods and have no statistical support for their results.
Recently [49], four viral genotyping tools for yellow fever (YFV) (https://
www.genomedetective.com/app/typingtool/yellowfevervirus/), dengue (DENV) 
(https://www.genomedetective.com/app/typingtool/dengue/), Chikungunya 
(CHIKV) (https://www.genomedetective.com/app/typingtool/chikungunya/) 
and Zika (ZIKV) (https://www.genomedetective.com/app/typingtool/zika/) were 
developed and linked to genome detective to enable phylogenetic classification 
below species level [50, 51].
6.1 Castor
The classification and annotation of virus genomes constitute important assets 
in the discovery of genomic variability, taxonomic characteristics and disease 
mechanisms. Existing classification methods are often designed for specific well-
studied families of viruses [43]. Thus, the viral comparative genomic studies could 
benefit from more generic, fast and accurate tools for classifying and typing newly 
sequenced strains of diverse virus families.
CASTOR is a virus classification platform based on machine learning methods, 
inspired by a well-known technique in molecular biology: restriction fragment 
length polymorphism [52]. It simulates, in silico, the restriction digestion of 
genomic material by different enzymes into fragments. It uses two metrics to con-
struct feature vectors for machine learning algorithms in the classification step. The 
performance of CASTOR, its genericity and robustness could permit the conduct of 
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novel and accurate large-scale virus studies. The CASTOR web platform provides an 
open access, collaborative and reproducible machine learning classifiers. CASTOR 
can be accessed at (http://castor.bioinfo.uqam.ca).
7. Phylogenetic and phylodynamic tools
Phylogenetic tools are an extremely important resource used in the field of virol-
ogy to study viral evolution, trace the origin of epidemics, establish the mode of 
transmission, investigate the occurrence of drug resistance or determine the origin 
of the virus in different body compartments. Thus, the tools developed by bioin-
formatics are fundamental to monitor the evolution of viral diversity, supporting 
studies of genomic sequence analysis, crucial for the surveillance of viral polymor-
phism, the development of new therapeutic strategies, the development of vaccine 
products or the appropriate choice products. Toward the development of a global 
surveillance outbreak surveillance system, the advances below have been made.
7.1 Nextstrain (https://nextstrain.org/)
Nextstrain is a real-time pathogen evolution tracking platform that implements 
cutting-edge analysis and visualization of pathogen genome data [53]. It provides 
evolutionary information in the form of interactive visualizations to virologists, 
epidemiologists, public health officials and citizen scientists. It has been used to 
track various arboviral epidemics globally including West Nile Virus (WNV) in the 
Americas, Zika virus in 33 countries and Dengue virus outbreaks in 64 countries. 
The platform is continually updated with publicly available datasets to provide new 
insights into viral epidemic outbreaks globally in an intuitive and visually esthetic 
manner.
8. Functional prediction tools
In disease surveillance, understanding the effect of mutations detected in the 
viral genomes through the methods identified above is invaluable in the develop-
ment of relevant controls and interventions [47]. Many of these mutations serve as 
drug targets as well as provide insights into the response mechanism of the patho-
gens to existing interventions. A global surveillance system would therefore be 
incomplete without the capability to provide insights to the function of discovered 
mutations. Below we explore some of the tools that have been applied to understand 
the functional relevance of mutations found in arboviruses.
8.1 The SIFT (sorting intolerant from tolerant)
The SIFT algorithm predicts the effect of coding variants on protein function 
[54, 55]. Since its introduction in 2001, SIFT has become one of the standard tools 
for characterizing missense variation. It has a corresponding website that provides 
users with predictions on their variants.
9. Conclusion
Augmenting epidemiological data with insights from genomic data provides 
a powerful tool for surveillance and control of disease outbreaks. Advances in 
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bioinformatics particularly leverage large genomic datasets to determine pathogenic 
organisms responsible for the outbreak, the origin of the infection and mutations 
responsible unique phenotypic traits. This information is crucial for effective 
planning interventions and combating outbreaks. An area of research interest that 
remains to be explored is the development of online platforms to perform func-
tional analyses of statistically significant mutations in arboviruses. This informa-
tion is invaluable in the development of vaccines and identification of drug targets.
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Appendices and nomenclature
RT-qPCR real time quantitative polymerase chain reaction
NGS  next generation sequencing
DNA deoxyribonucleic acid
RNA ribonucleic acid
VIP  virus identification pipeline
TAR-VIR targeted viral
RdRp RNA-dependent RNA polymerase
YFV  yellow fever virus
DENV dengue virus
CHIKV Chikungunya virus
ZIKV Zika virus
WNV West Nile virus
SIFT  sorting intolerant from tolerant
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